Pay in 4 interest-free payments of $5.20 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
A 30-day guarantee is, functionally, no guarantee you will not see meaningful results inside 30 days regardless of the product quality
BPC-157 demonstrates a bell-shaped dose-response curve in several models, meaning too high a dose may reduce therapeutic effects. Sikiric, P
When to use IM injection Intramuscular is better when: Treating deep muscle injuries Want faster absorption Prefer muscle over fat injection Targeting specific muscle groups Most people use SubQ: SubQ is easier and works well IM not necessary for most BPC-157 uses IM more painful typically IM injection sites Best muscles: Glutes (butt, upper outer quadrant) Thighs (vastus lateralis - outer mid-thigh) Deltoids (shoulder muscle - advanced) Site selection: Choose muscle near injury if targeting specific area Rotate between muscles Requires longer needle than SubQ IM injection technique Different from SubQ: Longer needle (1-1.5 inch) 90-degree angle (straight in) Into muscle, not just under skin Inject slowly May feel more discomfort Not necessary for most BPC-157 users: SubQ works great
Its Phase 3 weight-loss figures (in the low-to-mid 20% range) and its late-2025 FDA filing belong to the combination product, not to standalone cagrilintide, which remains at the Phase 2 stage with a peer-reviewed monotherapy result of about 10.8% at 26 weeks
This balanced approach offers optimal energy and weight loss benefits for most users while minimizing side effects [1]
doi:10.1016/j.jad.2017.11.020 Kell G, Rao A, Beccaria G, Clayton P, Inarejos-Garca AM, Prodanov M
